Low-Pass Whole Genome Sequencing
Low-Pass Whole Genome Sequencing (LP-WGS or low-coverage whole-genome sequencing) is an inexpensive high-throughput technology for detecting genome-wide genetic variation in a multitude of species.
Low-Pass Whole Genome Sequencing (LP-WGS or low-coverage whole-genome sequencing) is an inexpensive high-throughput technology for detecting genome-wide genetic variation in a multitude of species.
GENEWIZ next-generation sequencing based cancer panels provide a complete solution for your cancer research studies from experimental design to advanced bioinformatics analysis.
Cancer panels use next generation sequencing (NGS) technology to target specific genes or mutations that have established relevancy to a particular cancer phenotype.
Single-cell ATAC-Seq (scATAC-Seq) utilizes microfluidics and molecular barcoding to investigate chromatin accessibility in hundreds to thousands of individual nuclei from a single sample.
Methylation sequencing is the process in which DNA methylation is quantified using sodium bisulfite and subsequent nucleotide base conversion. To uncover the methylome, GENEWIZ uses wet and dry lab solutions, including Methyl-Seq, for global whole genome and targeted 5-methylcytosine (5mC) detection.
GENEWIZ TargetGxOne™ custom gene panels provide targeted resequencing of any gene of interest via next generation sequencing (NGS).
GENEWIZ routinely sequences pre-made amplicons on Illumina platforms to answer a myriad of biological questions.